News

Registration Now Open for Catalyst Life Sciences Conference

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), announced that registration is open for the Catalyst Life Sciences Conference. The event will be held October 6-7, 2022 at the Omni Hotel in  Richmond, Virginia.

This conference is designed for scientists, engineers, entrepreneurs, incubators and biohubs, life science companies, technology transfer departments and economic development departments. The format consists of expert panels sharing their knowledge and engaging in dialog with the audience.

Joni L. Rutter, Ph.D. will be a keynote speaker. Dr. Rutter is the Acting Director of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). NCATS was established to transform the translational process so that new treatments and cures for disease can be delivered to patients faster.

Expert panel topics include: Best Practices for Building a High-Potential Company, Scientists and Engineers as Entrepreneurs, Raising Capital, Establishing and Building Ecosystems, Growing Pharmaceutical Manufacturing and R-D Cluster, and Partnering with Companies and Healthcare Systems. For the full agenda and speakers, visit: https://www.virginiacatalyst.org/agenda.html.

“The Virginia Catalyst and our major Virginia-based research universities, along with Virginia Bio are excited to host a major life sciences conference to share best practices and encourage collaborations. It is through this collaborative ecosystem that we are improving human health and further developing our life science economy by creating innovative companies, capital formation, and job creation,” said Michael Grisham, President & CEO, Virginia Catalyst.

To register: https://www.virginiacatalyst.org/registration.html

Recent News

10/13/2026

ISOThrive Final Phase 2 Results for MHS-1031 Announced at ACG 2026 Demonstrate Statistically Significant and Clinically Meaningful Improvement in Heartburn Frequency and Severity in NERD PPI-Partial Responders

ISOThrive Inc. announced final results from its Phase 2 trial of MHS-1031 in patients with non-erosive reflux disease (NERD) who experience an incomplete response to proton pump inhibitors (PPIs). Peter Swann, MD, Chief Medical Officer of ISOThrive, and David Johnson, MD MACG FASGE VGSF MACP, Professor of Medicine and Chief of Gastroenterology at Eastern Va …

10/13/2026

Virginia Western and Radford University sign 3 new agreements to create seamless transfer for medical laboratory science degree

Virginia Western Community College and Radford University celebrated a strengthened partnership on Monday, Oct. 12, that will enable seamless transfer for students in three health-related programs. Virginia Western President Laura J. Treanor and Radford President Bret Danilowicz signed the articulation agreements in a ceremony on the Virginia Western campus. Virginia Western students who meet all requirements and complete …

10/07/2026

Roanoke Lands $1 Million Federal Grant to Equip RoVa Labs Biotech Incubator

The Roanoke City Council has accepted a $1 million U.S. Small Business Administration grant to purchase advanced laboratory equipment for RoVa Labs, a biotechnology startup incubator that combines biomedical research facilities with business development support. Since opening in May 2026, RoVa Labs has grown to house nine research tenants, and officials say the new funding …